Phase 4Not yet recruitingINTERVENTIONAL
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
ClinicalTrials.gov · NCT07756359 · Registry updated: 2026-08-10
- Condition / research focus
- Pouch, Ileal; Pouches, Ileoanal; Bowel Diseases, Inflammatory
- Sponsor
- University of North Carolina, Chapel Hill
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2026-09. Completion: 2027-09 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Tirzepatide (drug) — also listed as: Zepbound
- Loperamide (drug) — also listed as: Imodium
- Diphenoxylate/Atropine (drug) — also listed as: Lomotil
Where the study takes place — 5 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Cedars Sinai Medical Center
Beverly Hills, California, United States
Site recruitment: Not reported - Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported - Washington University School of Medicine
St Louis, Missouri, United States
Site recruitment: Not reported - University of North Carolina
Chapel Hill, North Carolina, United States
Site recruitment: Not reported - University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported